Peter Roderick

849 total citations
30 papers, 510 citations indexed

About

Peter Roderick is a scholar working on Economics and Econometrics, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Peter Roderick has authored 30 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 10 papers in General Health Professions and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Peter Roderick's work include Pharmaceutical Economics and Policy (9 papers), Healthcare Policy and Management (6 papers) and Health Services Management and Policy (6 papers). Peter Roderick is often cited by papers focused on Pharmaceutical Economics and Policy (9 papers), Healthcare Policy and Management (6 papers) and Health Services Management and Policy (6 papers). Peter Roderick collaborates with scholars based in United Kingdom, Qatar and India. Peter Roderick's co-authors include Allyson M Pollock, Patricia McGettigan, Abhay Kadam, T W Meade, Cecily Kelleher, H Wilkes, P J Brennan, John Hutton, Laura Gathercole and Elizabeth Berry and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and BMJ.

In The Last Decade

Peter Roderick

30 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Roderick United Kingdom 12 134 105 66 61 46 30 510
Vincent D. Marshall United States 18 114 0.9× 57 0.5× 59 0.9× 107 1.8× 39 0.8× 62 802
Bander Balkhi Saudi Arabia 18 93 0.7× 154 1.5× 68 1.0× 108 1.8× 26 0.6× 67 792
Ana Paula Martins Portugal 14 78 0.6× 99 0.9× 51 0.8× 50 0.8× 136 3.0× 54 707
Piotr Merks Poland 15 140 1.0× 134 1.3× 40 0.6× 122 2.0× 73 1.6× 93 790
Uday Venkat Mateti India 14 72 0.5× 95 0.9× 81 1.2× 78 1.3× 37 0.8× 95 625
Isabel Cristina Martins Emmerick United States 15 144 1.1× 195 1.9× 25 0.4× 38 0.6× 38 0.8× 65 577
Bhuvan KC Malaysia 16 117 0.9× 114 1.1× 51 0.8× 159 2.6× 41 0.9× 60 677
Surachat Ngorsuraches United States 17 191 1.4× 286 2.7× 106 1.6× 97 1.6× 34 0.7× 72 769
Keitty Regina Cordeiro de Andrade Brazil 11 88 0.7× 72 0.7× 49 0.7× 98 1.6× 34 0.7× 18 580
Caroline Morris New Zealand 16 366 2.7× 195 1.9× 51 0.8× 139 2.3× 43 0.9× 57 1.1k

Countries citing papers authored by Peter Roderick

Since Specialization
Citations

This map shows the geographic impact of Peter Roderick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Roderick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Roderick more than expected).

Fields of papers citing papers by Peter Roderick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Roderick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Roderick. The network helps show where Peter Roderick may publish in the future.

Co-authorship network of co-authors of Peter Roderick

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Roderick. A scholar is included among the top collaborators of Peter Roderick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Roderick. Peter Roderick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Roderick, Peter. (2023). Regulating new drugs in India needs to be improved. SHILAP Revista de lepidopterología. 10. 100144–100144. 1 indexed citations
3.
Brhlíková, Petra, et al.. (2023). Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics. Journal of Pharmaceutical Policy and Practice. 16(1). 139–139. 1 indexed citations
4.
Brhlíková, Petra, et al.. (2022). Systemic antibiotic sales and WHO recommendations, India. Bulletin of the World Health Organization. 100(10). 610–619. 10 indexed citations
5.
Roderick, Peter, Alison Macfarlane, & Allyson M Pollock. (2020). Getting back on track: control of covid-19 outbreaks in the community. BMJ. 369. m2484–m2484. 14 indexed citations
6.
Pollock, Allyson M, et al.. (2020). Covid-19: why is the UK government ignoring WHO’s advice?. BMJ. 368. m1284–m1284. 38 indexed citations
7.
Roderick, Peter, Victoria Turner, Anne Readshaw, Omara Dogar, & Kamran Siddiqi. (2019). The global prevalence of tobacco use in type 2 diabetes mellitus patients: A systematic review and meta-analysis. Diabetes Research and Clinical Practice. 154. 52–65. 24 indexed citations
8.
Baker, Peter, Sharif Ismail, Taavi Tillmann, et al.. (2019). Going upstream – an umbrella review of the macroeconomic determinants of health and health inequalities. BMC Public Health. 19(1). 1678–1678. 67 indexed citations
9.
Pollock, Allyson M & Peter Roderick. (2018). Why we should be concerned about accountable care organisations in England’s NHS. BMJ. 360. k343–k343. 12 indexed citations
10.
Evans, Valerie, Peter Roderick, & Allyson M Pollock. (2018). Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India. BMJ Global Health. 3(2). e000263–e000263. 1 indexed citations
11.
Sutaria, Shailen, Peter Roderick, & Allyson M Pollock. (2017). Are radical changes to health and social care paving the way for fewer services and new user charges?. BMJ. 358. j4279–j4279. 8 indexed citations
12.
Pollock, Allyson M & Peter Roderick. (2017). Jeremy Hunt must consult properly on accountable care organisations. BMJ. 359. j5349–j5349. 2 indexed citations
14.
Pollock, Allyson M & Peter Roderick. (2015). Why the Queen's Speech on 19 May should include a bill to reinstate the NHS in England. BMJ. 350(apr29 1). h2257–h2257. 1 indexed citations
15.
Roderick, Peter, et al.. (2014). Will the new Government introduce an Indian Drugs Bill to deliver rational regulation of safe and effective drugs. Economic and political weekly. 49(33). 15–19. 19 indexed citations
16.
Pollock, Allyson M & Peter Roderick. (2014). Trust in the time of markets: protecting patient information. The Lancet. 383(9928). 1523–1524. 9 indexed citations
17.
Roderick, Peter & Allyson M Pollock. (2014). A wolf in sheep's clothing: how Monitor is using licensing powers to reduce hospital and community services in England under the guise of continuity. BMJ. 349(oct06 5). g5603–g5603. 2 indexed citations
18.
Roderick, Peter, et al.. (2014). India should introduce a new Drugs Act. The Lancet. 383(9913). 203–206. 11 indexed citations
19.
Pollock, Allyson M, David Price, Peter Roderick, et al.. (2012). How the Health and Social Care Bill 2011 would end entitlement to comprehensive health care in England. The Lancet. 379(9814). 387–389. 21 indexed citations
20.
Kelly, Steven, Elizabeth Berry, Peter Roderick, et al.. (1997). The identification of bias in studies of the diagnostic performance of imaging modalities.. British Journal of Radiology. 70(838). 1028–1035. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026